EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals

Brecht Attema iD, Outi Kummu iD, Sini Pitkänen iD, Jonna Weisell iD, Taina Vuorio iD, Erika Pennanen, Maria Vorimo, Jaana Rysä iD, Sander Kersten iD, Anna-Liisa Levonen iD, Jukka Hakkola iD

Archives of Toxicology · 2024

DOI: 10.1007/s00204-023-03658-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Brecht Attema und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Endocrine Disruptors. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Health, Academy of Finland, University of Oulu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Environmental exposure to endocrine-disrupting chemicals (EDCs) can lead to metabolic disruption, resulting in metabolic complications including adiposity, dyslipidemia, hepatic lipid accumulation, and glucose intolerance. Hepatic nuclear receptor activation is one of the mechanisms mediating metabolic effects of EDCs. Here, we investigated the potential to use a repeated dose 28-day oral toxicity test for identification of EDCs with metabolic endpoints. Bisphenol A (BPA), pregnenolone-16α-carbonitrile (PCN), and perfluorooctanoic acid (PFOA) were used as reference compounds. Male and female wild-type C57BL/6 mice were orally exposed to 5, 50, and 500 μg/kg of BPA, 1000, 10 000, and 100 000 µg/kg of PCN and 50 and 300 μg/kg of PFOA for 28 days next to normal chow diet. Primary endpoints were glucose tolerance, hepatic lipid accumulation, and plasma lipids. After 28-day exposure, no changes in body weight and glucose tolerance were observed in BPA-, PCN-, or PFOA-treated males or females. PCN and PFOA at the highest dose in both sexes and BPA at the middle and high dose in males increased relative liver weight. PFOA reduced plasma triglycerides in males and females, and increased hepatic triglyceride content in males. PCN and PFOA induced hepatic expression of typical pregnane X receptor (PXR) and peroxisome proliferator-activated receptor (PPAR)α target genes, respectively. Exposure to BPA resulted in limited gene expression changes. In conclusion, the observed changes on metabolic health parameters were modest, suggesting that a standard repeated dose 28-day oral toxicity test is not a sensitive method for the detection of the metabolic effect of EDCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocrine DisruptorsMiceAnimalsMaleFemaleMice, Inbred C57BLReceptors, Cytoplasmic and NuclearLiverGlucoseLipidsBenzhydryl Compounds

Stichwörter der Autor:innen

Endocrine-disrupting chemicals (EDCs)Glucose metabolismHepatic steatosisLipid metabolismMetabolic disruptionMetabolism-disrupting chemicalsNuclear receptors

Substanzen

Endocrine DisruptorsReceptors, Cytoplasmic and NuclearGlucoseLipidsBenzhydryl Compounds

Autor:innen und Institutionen

  • Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands.
  • Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • A.I. Virtanen-Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Finnish Institute of Occupational Health, Kuopio, Finland.
  • School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland. jukka.hakkola@oulu.fi.

ORCID-Profile: Brecht Attema, Outi Kummu, Sini Pitkänen, Jonna Weisell, Taina Vuorio, Jaana Rysä, Sander Kersten, Anna-Liisa Levonen, Jukka Hakkola

Förderung

  • H2020 Health
  • Academy of Finland
  • University of Oulu

Zitieren

APA

Attema, B., Kummu, O., Pitkänen, S., Weisell, J., Vuorio, T., Pennanen, E., Vorimo, M., Rysä, J., Kersten, S., Levonen, A. L., & Hakkola, J. (2024). Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals. Archives of Toxicology. https://doi.org/10.1007/s00204-023-03658-2

Vancouver

Attema B, Kummu O, Pitkänen S, Weisell J, Vuorio T, Pennanen E, et al. Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals. Archives of Toxicology. 2024. doi:10.1007/s00204-023-03658-2

BibTeX
@article{Attema2024,
  author = {Attema, Brecht and Kummu, Outi and Pitkänen, Sini and Weisell, Jonna and Vuorio, Taina and Pennanen, Erika and Vorimo, Maria and Rysä, Jaana and Kersten, Sander and Levonen, Anna-Liisa and Hakkola, Jukka},
  title = {Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals},
  journal = {Archives of Toxicology},
  year = {2024},
  doi = {10.1007/s00204-023-03658-2}
}
Kostenlos starten →